Medtronic Freestyle Valve Durability Claim Discussions With FDA Are Ongoing
This article was originally published in The Gray Sheet
Medtronic and FDA are discussing both the data requirements to substantiate durability claims for the Freestyle heart valve and currently appropriate statements for promotional and advertising materials in the wake of a May 12 warning letter from the agency.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.